(Date:11/23/2009)...Nov.23/PRNewswire/--PearlTherapeuticsInc.,abiophar...hetreatmentofchronicrespiratorydiseases,todayannou...fDirectors.Mr.Rosenhas25yearsofexperienceinthephar...olesatGileadSciencesandALZACorporation.Hisappointm...x. ,, "Howiebringsawealthofproductdevelopment,c...
(Date:11/20/2009)...0 Dendreon Corporation (... and Drug Administration (FDA) provided written ac... License Application (BLA) for PROVENGE® (sip...signed a Prescription Drug User Fee Act (PDUFA) da...o Dendreon,s amended BLA. Dendreon is seeking lic...
(Date:11/20/2009)...ETTLER TOLEDO recently announced that Dr. Dominiqu... Role of Process Analytical Technology (PAT) in Gr...mber 1, 2009. , (PRWEB) N...s Analytical Technology (PAT) in Green Chemistry a...ss Analytical Technology (PAT) case studies will b...
(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...usly reported $6.3 million registered direct place...s of its common stock and warrants to purchase up ...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3...ent, BASEL, Switzerland and TUCSON, Ariz., Jan. 2...d-leading healthcare,provider of pharmaceuticals a...ana") (Nasdaq: VMSI ) today announced that they h...e terms of the agreement, Roche will,increase the ...mon shares,to $89.50 per share in cash (or an aggr...
...x,Orthobiology B.V. announced today the closure of...y BioGeneration Ventures., Progentix Orthobiology...e suite of osteoinductive material products for cl...rogentix bone graft material is based on,surface s...the ability to,attract growth factors and stems ce...
...s,announced that it will continue to provide Avast...thalmologists who request it for their patients.,T..., Genentech,s, decision,( http://www.lucentis.com/...Avastin directly to compounding pharmacies as of J...tinal specialists and,ophthalmologists to treat ag...
Other Biology Technology:Roche to Acquire Ventana for $89.50 per share 2Roche to Acquire Ventana for $89.50 per share 3Roche to Acquire Ventana for $89.50 per share 4Roche to Acquire Ventana for $89.50 per share 5Roche to Acquire Ventana for $89.50 per share 6Progentix Orthobiology B.V. Closes Series A Financing Round 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 3(Date:11/23/2009)... , Sewer overflows are a nasty business, posing d...Carolina State University is launching a new proje...tion Agency (EPA) that targets the fat and grease ...r, and will give urban planners new tools to furth...are overflows from "sanitary" sewer systems, as op...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
(Date:11/22/2009)... , A commonly inherited gene deletion can increas... bone marrow transplantation, an international tea...e online issue of Nature Genetics . When the gene...me but present in the recipient,s, transplants hav...ffect known as graft-versus-host disease, in which...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 1BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 2Reverse Ages Staying Young Naturally 50696 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 5...ctors from different hospitals can collaborate on ...rating room. What if doctors in remote locations c...cialists in hospitals around the world? , This en...search by a multi-university partnership that is t...dvanced networking consortium Internet2. , Roche...
...g is causing the worldwide declines of amphibians ...cording to biologists. The findings, which contrad...is killing the frogs and toads and aid in their co... sixth mass extinction event," said Peter Hudson, ...d co-author of the research study. "And amphibians...
...matodes are extreme parasites. These microscopic, ...ral and field crops in sub-tropical regions, resul...d gardeners. , Until recently, fumigation of the ...rimary method for controlling root-knot nematodes ... is an odorless, colorless gas that has been widel...
Other Biology News:The next step in health care: Telemedicine 2Global warming link to amphibian declines in doubt 2Global warming link to amphibian declines in doubt 3Parasite-resistant peppers green alternatives to chemical pesticides 2Eosinophil Chip-IHC from 3H Biomedical AB
B Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
Biology Products: